Company profile
Cognito Therapeutics company profile
Cognito Therapeutics is a clinical-stage neurotechnology business focused on creating disease-modifying pharmaceutical methods for the treatment of neurodegenerative illnesses. Li-Huei Tsai and Ed Boyden, MIT Professors, and scientific founders, created its non-invasive neuromodulation platform. The Company's primary therapy is now being studied in a pivotal study for Alzheimer's Disease and has been designated as a Breakthrough Device by the FDA.
Business identity
- Website
- https://www.cognitotx.com
- Contact email
- [email protected]
- Phone number
- 857-201-5088
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2016-01-01, Year
Headquarters
- Headquarters
- Primghar, Iowa, United States
- Postal code
- 02138
- Country code
- US
- Continent
- North America